查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2107915

區塊鏈市場分析及2035年醫療保健供應鏈預測：按類型、產品、服務、技術、組件、應用、流程、部署、最終用戶和解決方案分類

Blockchain for Medical Supply Chains Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Process, Deployment, End User, Solutions
出版日期: | 出版商: Global Insight Services | 英文 350 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球醫療保健供應鏈區塊鏈市場預計將從2025年的18億美元成長到2035年的84億美元，複合年成長率（CAGR）為16.4%。隨著製藥廠商、經銷商和醫療服務提供者將產品可追溯性和防偽放在首位，該市場正穩步擴張。產業預測，到2025年，該市場規模將達到數億美元，並在未來十年以超過20%的複合年成長率持續成長。支持藥品序列化、數位化供應鏈現代化和安全醫療數據交換的監管措施持續刺激市場需求。包括美國食品藥物管理局（FDA）實施的《藥品供應鏈安全法案》（DSCA）在內的公共部門舉措，以及全球醫療保健數位化舉措，正在推動對基於區塊鏈的供應鏈基礎設施和可互操作數位生態系統的投資。

該產品板塊涵蓋軟體應用、區塊鏈平台和中間件解決方案，旨在實現醫療保健供應鏈營運的數位化和安全化。軟體支援產品真偽驗證、庫存視覺化、序列化和合規性管理，而區塊鏈平台則提供防篡改的交易記錄和用於多方協作的分散式帳本。中間件將區塊鏈與企業資源計劃 (ERP)、倉庫管理、物聯網感測器和雲端基礎設施整合，以確保相關人員之間的無縫互通性。製藥業的數位化程度不斷提高，對端到端可追溯性、防偽措施以及供應鏈即時可視化的需求日益成長，正在加速相關技術的應用，而產品創新則是推動市場長期成長的關鍵因素。

市場區隔
類型 公有區塊鏈、私有區塊鏈、聯盟區塊鏈、混合區塊鏈等等。
產品 區塊鏈平台、區塊鏈即服務 (BaaS)、區塊鏈軟體及其他
服務 諮詢、整合、支援和維護、培訓和教育以及其他服務。
科技 分散式帳本技術（DLT）、智慧合約、密碼安全、代幣化等。
成分 硬體、軟體、服務及其他
目的 藥品可追溯性、供應鏈透明度、庫存管理、臨床試驗、仿冒品檢測等等。
流程 交易處理、資料管理、身分管理、合規與稽核等。
發展 本地部署、雲端部署、混合部署及其他
最終用戶 製藥公司、醫療機構、物流和分銷商、監管機構及其他
解決方案 供應鏈最佳化、詐欺防制、監管合規、資料安全等等。

服務部門致力於支援基於區塊鏈的醫療保健供應鏈解決方案的成功實施、最佳化和生命週期管理。諮詢服務評估營運準備、合規性要求和實施策略，並在整合和部署過程中將區塊鏈與現有企業應用和物流系統無縫整合。支援和維護服務確保系統可靠性、網路安全、效能最佳化和軟體升級。培訓和教育提升員工在區塊鏈管治、智慧合約和法規遵循方面的能力。實施的日益複雜、數位轉型 (DX) 專案的興起以及跨境藥品分銷的擴張，都推動了對具備醫療保健和區塊鏈專業知識的專業服務供應商的需求。

區域概覽

北美憑藉其先進的製藥生產生態系統、強大的醫療IT基礎設施以及對數位技術的早期應用，在醫療保健供應鏈區塊鏈市場佔據了舉足輕重的地位。該地區受益於藥品序列化要求的廣泛實施、成熟的區塊鏈技術供應商的存在以及對供應鏈現代化的巨額投資。醫療服務提供者、製藥公司、物流供應商和技術公司之間的緊密合作為商業部署提供了有力支持。政府主導的法規結構促進了產品安全可追溯性，加上網路安全意識的不斷增強和雲端運算的日益普及，共同推動了該地區對基於區塊鏈的醫療保健供應鏈解決方案的持續成長需求。

在亞太地區，隨著藥品生產能力的擴張、醫療保健領域投資的增加以及醫療物流數位轉型的加速，市場展現出強勁的成長動能。中國、印度、日本、韓國和新加坡等國家正在投資區塊鏈創新、智慧物流和醫療保健領域的數位基礎設施，以提高供應鏈的韌性。藥品出口的快速成長、對假藥日益成長的擔憂以及分銷網路的現代化，都在推動區塊鏈技術的更廣泛應用。官民合作關係、不斷擴展的雲端基礎設施以及支援技術應用的政策，為解決方案供應商提供了在整個區域醫療保健供應鏈生態系統中擴展部署的機會。

主要趨勢和促進因素

提高可追溯性和透明度：

將區塊鏈技術融入醫療供應鏈，顯著提升了其可追溯性和透明度。區塊鏈提供去中心化、防篡改的帳本，使相關人員能夠追蹤醫療用品從製造商到最終用戶的流轉過程。這種透明度有助於減少欺詐，確保醫療產品的真實性，並簡化整個供應鏈。隨著監管機構對可追溯性標準的要求日益提高，區塊鏈在提供即時、檢驗資料方面的作用也變得至關重要。

對藥品端到端可追溯性的需求正在推動市場成長：

監管機構日益重視藥品溯源、假藥防範和透明的供應鏈運營，這正在推動區塊鏈技術的應用。醫療機構正在尋求防篡改的交易記錄、安全的資料共用和端到端的產品可視性，以提高營運效率、保障病患安全、最佳化庫存管理，並促進製造商、經銷商、醫療服務提供者和監管機構之間的協作，同時遵守不斷變化的法規。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制因素
  • 複合年均成長率分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章：細分市場分析

  • 市場規模及預測：依類型
    • 公共區塊鏈
    • 私有區塊鏈
    • 聯盟區塊鏈
    • 混合區塊鏈
    • 其他
  • 市場規模及預測：依產品分類
    • 區塊鏈平台
    • BaaS
    • 區塊鏈軟體
    • 其他
  • 市場規模及預測：依服務分類
    • 諮詢
    • 一體化
    • 支援與維護
    • 培訓和教育
    • 其他
  • 市場規模及預測：依技術分類
    • 分散式帳本技術（DLT）
    • 智慧合約
    • 加密安全
    • 分詞
    • 其他
  • 市場規模及預測：依組件分類
    • 硬體
    • 軟體
    • 服務
    • 其他
  • 市場規模及預測：依應用領域分類
    • 藥品可追溯性
    • 供應鏈透明度
    • 庫存管理
    • 臨床試驗
    • 仿冒品檢測
    • 其他
  • 市場規模及預測：依製程分類
    • 交易處理
    • 資料管理
    • 身分管理
    • 合規與審計
    • 其他
  • 市場規模及預測：依市場細分
    • 現場
    • 基於雲端的
    • 混合
    • 其他
  • 市場規模及預測：依最終用戶分類
    • 製藥公司
    • 醫療機構
    • 物流/配送
    • 監管機構
    • 其他
  • 市場規模及預測：按解決方案分類
    • 供應鏈最佳化
    • 防範詐欺
    • 監理合規
    • 資料安全
    • 其他

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲國家
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 其他亞太國家
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲國家

第6章 市場策略

  • 供需差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 監管概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 大公司的策略

第8章：公司簡介

  • IBM
  • Oracle
  • SAP
  • Chronicled
  • Modum
  • Guardtime
  • R3
  • VeChain
  • Factom
  • Hashed Health
  • SimplyVital Health
  • Blockpharma
  • MediLedger
  • Embleema
  • Solve.Care
  • Farmatrust
  • Ambrosus
  • Everledger
  • Provenance
  • Tierion

第9章 關於我們

簡介目錄
Product Code: GIS10553

The global Blockchain for Medical Supply Chains Market is projected to grow from $1.8 billion in 2025 to $8.4 billion by 2035, at a compound annual growth rate (CAGR) of 16.4%. The Blockchain for Medical Supply Chains Market is expanding steadily as pharmaceutical manufacturers, distributors, and healthcare providers prioritize product traceability and counterfeit prevention. Industry assessments estimate the market at several hundred million dollars in 2025, with projected double-digit CAGR exceeding 20% through the next decade. Regulatory initiatives supporting pharmaceutical serialization, digital supply chain modernization, and secure health data exchange continue to stimulate demand. Official organizations including the U.S. Food and Drug Administration through Drug Supply Chain Security Act implementation, alongside global healthcare digitalization initiatives, reinforce investment in blockchain-enabled supply chain infrastructure and interoperable digital ecosystems.

The product segment includes software applications, blockchain platforms, and middleware solutions designed to digitize and secure medical supply chain operations. Software enables product authentication, inventory visibility, serialization, and compliance management, while blockchain platforms provide decentralized ledgers for immutable transaction records and multi-party collaboration. Middleware integrates blockchain with enterprise resource planning, warehouse management, IoT sensors, and cloud infrastructure, ensuring seamless interoperability across stakeholders. Increasing pharmaceutical digitization, demand for end-to-end traceability, anti-counterfeit initiatives, and real-time supply chain visibility continue to accelerate adoption, making product innovation a major contributor to long-term market expansion.

Market Segmentation
TypePublic Blockchain, Private Blockchain, Consortium Blockchain, Hybrid Blockchain, Others
ProductBlockchain Platforms, Blockchain-as-a-Service (BaaS), Blockchain Software, Others
ServicesConsulting, Integration, Support and Maintenance, Training and Education, Others
TechnologyDistributed Ledger Technology, Smart Contracts, Cryptographic Security, Tokenization, Others
ComponentHardware, Software, Services, Others
ApplicationDrug Traceability, Supply Chain Transparency, Inventory Management, Clinical Trials, Counterfeit Detection, Others
ProcessTransaction Processing, Data Management, Identity Management, Compliance and Audit, Others
DeploymentOn-Premises, Cloud-Based, Hybrid, Others
End UserPharmaceutical Companies, Healthcare Providers, Logistics and Distribution, Regulatory Authorities, Others
SolutionsSupply Chain Optimization, Fraud Prevention, Regulatory Compliance, Data Security, Others

The services segment supports successful implementation, optimization, and lifecycle management of blockchain-enabled medical supply chain solutions. Consulting services evaluate operational readiness, compliance requirements, and deployment strategies, while integration and deployment connect blockchain with existing enterprise applications and logistics systems. Support and maintenance ensure system reliability, cybersecurity, performance optimization, and software upgrades. Training and education improve workforce capability in blockchain governance, smart contracts, and regulatory compliance. Growing implementation complexity, increasing digital transformation projects, and expanding cross-border pharmaceutical distribution are strengthening demand for specialized service providers with healthcare and blockchain expertise.

Geographical Overview

North America maintains a substantial share of the Blockchain for Medical Supply Chains Market due to its advanced pharmaceutical manufacturing ecosystem, strong healthcare IT infrastructure, and early adoption of digital technologies. The region benefits from extensive implementation of pharmaceutical serialization requirements, established blockchain technology vendors, and significant investment in supply chain modernization. Strong collaboration among healthcare providers, pharmaceutical companies, logistics providers, and technology firms supports commercial deployment. Government-backed regulatory frameworks promoting secure product traceability, combined with increasing cybersecurity awareness and cloud adoption, continue to strengthen regional demand for blockchain-enabled medical supply chain solutions.

Asia-Pacific demonstrates considerable market momentum through expanding pharmaceutical manufacturing capacity, rising healthcare investments, and accelerating digital transformation across healthcare logistics. Countries including China, India, Japan, South Korea, and Singapore are investing in blockchain innovation, smart logistics, and healthcare digital infrastructure to improve supply chain resilience. Rapid expansion of pharmaceutical exports, increasing concerns regarding counterfeit medicines, and modernization of distribution networks encourage wider blockchain deployment. Public-private partnerships, growing cloud infrastructure, and favorable technology adoption policies create opportunities for solution providers to expand implementation across regional healthcare supply chain ecosystems.

Key Trends and Drivers

Enhanced Traceability and Transparency:

The integration of blockchain technology into medical supply chains is significantly enhancing traceability and transparency. By providing a decentralized and immutable ledger, blockchain allows stakeholders to track the movement of medical supplies from manufacturers to end-users. This transparency helps in reducing fraud, ensuring the authenticity of medical products, and improving overall supply chain efficiency. As regulatory bodies increasingly demand higher standards of traceability, blockchain's role in providing real-time, verifiable data is becoming indispensable.

Demand for End-to-End Drug Traceability Fuels Market Growth:

Growing regulatory emphasis on pharmaceutical traceability, counterfeit drug prevention, and transparent supply chain operations is driving adoption of blockchain technologies. Healthcare organizations seek immutable transaction records, secure data sharing, and end-to-end product visibility to comply with evolving regulations while improving operational efficiency, patient safety, inventory management, and collaboration among manufacturers, distributors, healthcare providers, and regulatory agencies.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by Process
  • 2.8 Key Market Highlights by Deployment
  • 2.9 Key Market Highlights by End User
  • 2.10 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Public Blockchain
    • 4.1.2 Private Blockchain
    • 4.1.3 Consortium Blockchain
    • 4.1.4 Hybrid Blockchain
    • 4.1.5 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Blockchain Platforms
    • 4.2.2 Blockchain-as-a-Service (BaaS)
    • 4.2.3 Blockchain Software
    • 4.2.4 Others
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Consulting
    • 4.3.2 Integration
    • 4.3.3 Support and Maintenance
    • 4.3.4 Training and Education
    • 4.3.5 Others
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Distributed Ledger Technology
    • 4.4.2 Smart Contracts
    • 4.4.3 Cryptographic Security
    • 4.4.4 Tokenization
    • 4.4.5 Others
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Hardware
    • 4.5.2 Software
    • 4.5.3 Services
    • 4.5.4 Others
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Drug Traceability
    • 4.6.2 Supply Chain Transparency
    • 4.6.3 Inventory Management
    • 4.6.4 Clinical Trials
    • 4.6.5 Counterfeit Detection
    • 4.6.6 Others
  • 4.7 Market Size & Forecast by Process (2020-2035)
    • 4.7.1 Transaction Processing
    • 4.7.2 Data Management
    • 4.7.3 Identity Management
    • 4.7.4 Compliance and Audit
    • 4.7.5 Others
  • 4.8 Market Size & Forecast by Deployment (2020-2035)
    • 4.8.1 On-Premises
    • 4.8.2 Cloud-Based
    • 4.8.3 Hybrid
    • 4.8.4 Others
  • 4.9 Market Size & Forecast by End User (2020-2035)
    • 4.9.1 Pharmaceutical Companies
    • 4.9.2 Healthcare Providers
    • 4.9.3 Logistics and Distribution
    • 4.9.4 Regulatory Authorities
    • 4.9.5 Others
  • 4.10 Market Size & Forecast by Solutions (2020-2035)
    • 4.10.1 Supply Chain Optimization
    • 4.10.2 Fraud Prevention
    • 4.10.3 Regulatory Compliance
    • 4.10.4 Data Security
    • 4.10.5 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 Process
      • 5.2.1.8 Deployment
      • 5.2.1.9 End User
      • 5.2.1.10 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 Process
      • 5.2.2.8 Deployment
      • 5.2.2.9 End User
      • 5.2.2.10 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 Process
      • 5.2.3.8 Deployment
      • 5.2.3.9 End User
      • 5.2.3.10 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 Process
      • 5.3.1.8 Deployment
      • 5.3.1.9 End User
      • 5.3.1.10 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 Process
      • 5.3.2.8 Deployment
      • 5.3.2.9 End User
      • 5.3.2.10 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 Process
      • 5.3.3.8 Deployment
      • 5.3.3.9 End User
      • 5.3.3.10 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 Process
      • 5.4.1.8 Deployment
      • 5.4.1.9 End User
      • 5.4.1.10 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 Process
      • 5.4.2.8 Deployment
      • 5.4.2.9 End User
      • 5.4.2.10 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 Process
      • 5.4.3.8 Deployment
      • 5.4.3.9 End User
      • 5.4.3.10 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 Process
      • 5.4.4.8 Deployment
      • 5.4.4.9 End User
      • 5.4.4.10 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 Process
      • 5.4.5.8 Deployment
      • 5.4.5.9 End User
      • 5.4.5.10 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 Process
      • 5.4.6.8 Deployment
      • 5.4.6.9 End User
      • 5.4.6.10 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 Process
      • 5.4.7.8 Deployment
      • 5.4.7.9 End User
      • 5.4.7.10 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 Process
      • 5.5.1.8 Deployment
      • 5.5.1.9 End User
      • 5.5.1.10 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 Process
      • 5.5.2.8 Deployment
      • 5.5.2.9 End User
      • 5.5.2.10 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 Process
      • 5.5.3.8 Deployment
      • 5.5.3.9 End User
      • 5.5.3.10 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 Process
      • 5.5.4.8 Deployment
      • 5.5.4.9 End User
      • 5.5.4.10 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 Process
      • 5.5.5.8 Deployment
      • 5.5.5.9 End User
      • 5.5.5.10 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 Process
      • 5.5.6.8 Deployment
      • 5.5.6.9 End User
      • 5.5.6.10 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 Process
      • 5.6.1.8 Deployment
      • 5.6.1.9 End User
      • 5.6.1.10 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 Process
      • 5.6.2.8 Deployment
      • 5.6.2.9 End User
      • 5.6.2.10 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 Process
      • 5.6.3.8 Deployment
      • 5.6.3.9 End User
      • 5.6.3.10 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 Process
      • 5.6.4.8 Deployment
      • 5.6.4.9 End User
      • 5.6.4.10 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 Process
      • 5.6.5.8 Deployment
      • 5.6.5.9 End User
      • 5.6.5.10 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 IBM
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Oracle
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 SAP
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Chronicled
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Modum
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Guardtime
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 R3
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 VeChain
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Factom
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Hashed Health
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 SimplyVital Health
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Blockpharma
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 MediLedger
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Embleema
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Solve.Care
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Farmatrust
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Ambrosus
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Everledger
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Provenance
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Tierion
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us